Related Experiment Video
Updated: Aug 1, 2026
Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
Published on: June 27, 2015
TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis
1Institut für Anatomie und Zellbiologie, Universität Heidelberg, INF 307, D69120 Heidelberg, Germany. wilhelm.kriz@urz.uni-heidelberg.de
Abstract:
Hereditary kidney diseases have long been an enigma with respect to the identity of the mutated genes and the mechanisms by which they develop. Recently, the podocyte has been identified as a primary target in both genetic and acquired glomerular disorders. Mutations discovered by Winn et al. and Reiser et al. in the gene encoding TRPC6, a non-selective cation channel of the TRP family expressed in podocyte foot processes, have been shown to cause focal segmental glomerulosclerosis. It remains to be determined whether these mutations lead to (i) impaired channel function that initiates a new pathogenic mechanism or (ii) decreased ability of the podocyte to adapt to normal physiological challenges that account for disease development, as suggested for other late-onset autosomal-dominant podocyte disorders.
Insights
Mutations in the TRPC6 gene cause focal segmental glomerulosclerosis by affecting podocyte function. Further research is needed to understand if these mutations impair channel function or podocyte adaptation to physiological challenges.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Hereditary kidney diseases present diagnostic challenges regarding causative genes and pathogenic mechanisms.
- The podocyte is increasingly recognized as a key cellular target in glomerular diseases, both genetic and acquired.
- Recent discoveries link mutations in the TRPC6 gene to focal segmental glomerulosclerosis (FSGS).
Purpose of the Study:
- To investigate the pathogenic mechanisms underlying TRPC6-associated FSGS.
- To determine whether identified TRPC6 mutations impair channel function or reduce podocyte adaptability.
Main Methods:
- Analysis of mutations in the TRPC6 gene.
- Investigation of TRPC6 channel function in podocytes.
- Assessment of podocyte response to physiological stress.
Main Results:
- Mutations in the TRPC6 gene are associated with focal segmental glomerulosclerosis.
- TRPC6, a cation channel in podocyte foot processes, is implicated in FSGS pathogenesis.
- The precise mechanism—impaired channel function versus reduced podocyte adaptation—requires further elucidation.
Conclusions:
- TRPC6 mutations represent a significant genetic cause of FSGS.
- Understanding the functional consequences of TRPC6 mutations is crucial for developing targeted therapies.
- Further studies are warranted to differentiate between direct channel dysfunction and adaptive capacity reduction in TRPC6-related podocytopathies.
